Since December 2019, in Leiden, Teun van Gelder has a position as Professor in Clinical Pharmacology, especially in Drug Discovery & Drug Development. He is a member of the board of the Stichting Nationaal Farmaceutisch Kenniscentrum. In 2020 he received the Poulsson Award of the Norwegian Society for Pharmacology & Toxicology, and in 2022 the Charles E Pippenger Award from IATDMCT.

More information about Teun van Gelder

Since December 2019, in Leiden,  Teun van Gelder has a position as Professor in Clinical Pharmacology, especially in Drug Discovery & Drug Development. He is a member of the board of the Stichting Nationaal Farmaceutisch Kenniscentrum.  In 2020 he received the Poulsson Award of the Norwegian Society for Pharmacology & Toxicology, and in 2022 the Charles E Pippenger Award from IATDMCT.

Academic Pharma

Teun van Gelder is appointed in the stimulation field Translational Drug Discovery & Development. This offers the opportunity to develop novel pharmaceutical compounds.

Innovations for rare diseases need a stimulus to progress further in development, and should reach the patient for a price which is acceptable for society. We envision that combining smart technology and new forms of regulation and cooperation in public private partnerships (PPP’s) will boost the potential for development and accessibility of therapies for rare diseases.  

The activities will be closely linked to the national ZonMW program Future Affordable and Sustainable Therapies (FAST).

Academic career

Teun van Gelder is an internist-clinical pharmacologist.  He was trained in internal medicine and nephrology at the Erasmus Medical Center, and completed his thesis in 1996 on the use of anti-interleukin-2 receptor monoclonal antibodies in solid organ transplantation. As a post-doctoral scientist, he worked in the Transplantation Immunology Laboratory of Dr. Randall E. Morris at Stanford University (1998-2000).

Between 2000 and 2019 he worked in the Departments of Hospital Pharmacy and Internal Medicine at the Erasmus Medical Center in Rotterdam, the Netherlands. In 2010, at Erasmus Medical Center  he was appointed Professor in Clinical Pharmacology. His research at the Erasmus Medical Center was focused on clinical pharmacology and therapeutic drug monitoring.

In December 2019 Teun van Gelder accepted a new position in Leiden University Medical Center (LUMC).  He was appointed Professor in Drug Discovery & Development. LUMC, Leiden Institute of Chemistry, Leiden Academic Centre for Drug Research (LACDR), Centre for Human Drug Research (CHDR) and Leiden Bio Science Park (LBSP) together have the expertise and facilities for the design, development and testing of new innovative drugs. This environment is unique in the Netherlands, and provides an excellent basis for drug discovery and drug development.